|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2300071698 |
|
最近更新日期: Date of Last Refreshed on: |
2023-07-23 11:57:56 |
|
注册时间: Date of Registration: |
2023-05-23 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
中国消化道疾病整合研究队列 (NAGIS队列) |
|
Public title: |
Gastrointestinal Diseases Cohort Study in China (NAGIS) |
|
注册题目简写: |
NAGIS队列研究 |
|
English Acronym: |
NAGIS Cohort Study |
|
研究课题的正式科学名称: |
消化道疾病临床队列建设及其可用性研究 |
|
Scientific title: |
Gastrointestinal Diseases Cohort Study in China (NAGIS) |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
郑荣 |
研究负责人: |
吴开春 |
|
Applicant: |
Rong Zheng |
Study leader: |
Kaichun Wu |
|
申请注册联系人电话: Applicant telephone: |
+86 198 2975 8242 |
研究负责人电话:
Study leader's |
+86 137 0921 8743 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
zhengrong4956@163.com |
研究负责人电子邮件: Study leader's E-mail: |
zhengrong4956@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
西安市新城区长乐西路127号 |
研究负责人通讯地址: |
西安市新城区长乐西路127号 |
|
Applicant address: |
127 Changle Road West, Xincheng District, Xi'an, Shaan Xi |
Study leader's address: |
127 Changle Road West, Xincheng District, Xi'an, Shaan Xi |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
空军军医大学第一附属医院 |
||
|
Applicant's institution: |
The First Affiliated Hospital of Air Force Military Medical University |
||
|
研究负责人所在单位: |
空军军医大学第一附属医院 |
||
|
Affiliation of the Leader: |
The First Affiliated Hospital of Air Force Military Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
KY20222241-X-1 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
中国人民解放军空军军医大学第一附属医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of the First Affiliated Hospital of the PLA Air Force Military Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-10-21 00:00:00 | ||
|
伦理委员会联系人: |
伦理机构办公室 |
||
|
Contact Name of the ethic committee: |
Ethics Office |
||
|
伦理委员会联系地址: |
西安市新城区长乐西路127号 |
||
|
Contact Address of the ethic committee: |
127 Changle Road West, Xincheng District, Xi'an, Shaan Xi |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 29 8477 1794 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
国家消化系统疾病临床医学研究中心/空军军医大学第一附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
National Clinical Research Center for Digestive Diseases/The First Affiliated Hospital of Air Force Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
西安市新城区长乐西路127号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
127 Changle Road West, Xincheng District, Xi'an, Shaan Xi |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
国家消化系统疾病临床医学研究中心、国家重点研发计划、国家消化道疾病整合研究合作联盟 |
||||||||||||||||||||||
|
Source(s) of funding: |
National Clinical Research Center for Digestive DiseasesNational Key R&D Program of ChinaNational Alliance for Gastrointestinal Integrative Studies (NAGIS) |
||||||||||||||||||||||
|
研究疾病: |
消化道疾病 |
||||||||||||||||||||||
|
Target disease: |
Gastrointestinal Diseases |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
建立涵盖消化道良性疾病、消化道肿瘤高危人群、早癌和进展期癌的全病程临床研究队列,搭建大数据采集平台,并开展多中心研究。为我国消化道常见病及消化肿瘤高危人群精准筛查和优化诊疗决策奠定基础。 |
||||||||||||||||||||||
|
Objectives of Study: |
To establish a full-course clinical cohort which covering healthy controls, gastrointestinal benign diseases, pre-cancerous lesions, early and advanced gastrointestinal cancers in China. The data will facilitate recognition, diagnosis, and treatment of gastrointestinal benign and malignant diseases. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
疾病组: 1.年龄大于18岁; 2.符合消化道消化道良性疾病(消化道息肉、胃食管反流病、消化道溃疡、糜烂性胃肠炎、胃肠道间质瘤及其他黏膜下肿瘤、炎症性肠病、非特异性肠炎等)、消化系肿瘤高危人群或原发性早癌或进展期消化道肿瘤诊断。 健康组: 1.年龄大于18岁; 2.经胃肠镜检查无消化道良恶性疾病。 |
||||||||||||||||||||||
|
Inclusion criteria |
Disease group 1. Aged over 18 years; 2. The diagnosis of gastrointestinal (esophagus, stomach, colon or rectum) benign diseases (gastrointestinal polyps, gastroesophageal reflux disease, digestive ulcer, erosive gastroenteritis, gastrointestinal stromal tumor and other submucosal tumors, inflammatory bowel disease, nonspecific enteritis, etc.), pre-cancerous lesions, early and advanced gastrointestinal cancers in China. Health group: 1. Aged over 18 years; 2. No benign or malignant diseases of digestive tract. |
||||||||||||||||||||||
|
排除标准: |
1.研究者认为其他不适合进入研究的患者; 2.无法签署知情同意书等相关文书的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Other patients deemed unsuitable for study by the investigator; 2. Patients who are unable to sign the informed consent. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-08-15 00:00:00至 To 2032-08-14 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-06-01 00:00:00 至 To 2032-08-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
不适用 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
N/A |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
N/A |
|
Blinding: |
N/A |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
根据研究进程,择期选择具体方式公开原始数据。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
According to the research process, choose a specific method to disclose the original data. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
电子采集和管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
EDC |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |